EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Stage-specific pharmacodynamic chloroquine and pyronaridine action on artemisinin ring-stage resistant Kelch C580Y mutation Plasmodium falciparum correlates to hemozoin inhibition process

Abeer Sayeed, Revie Atkinson, Peter G Vekilov, Jeffrey D Rimer, David J Sullivan iD

Antimicrobial Agents and Chemotherapy · 2025

DOI: 10.1128/aac.01208-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Abeer Sayeed und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Plasmodium falciparum, Chloroquine, Antimalarials, Hemeproteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Bloomberg Family Foundation (The Bloomberg Family Foundation), JHSPH | Johns Hopkins Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The antimalarial quinolines pyronaridine and chloroquine both inhibit hemozoin crystallization, predominately produced by Plasmodium falciparum intra-erythrocytic trophozoite stage parasites. Pyronaridine extends activity to ring-stage chloroquine-sensitive parasites, in contrast to chloroquine. Here, we investigated chloroquine and pyronaridine hemozoin inhibition type correlated to stage-specific activity on chloroquine-resistant ring-stage artemisinin sensitive and resistant P. falciparum CamWT and CamWT-C580Y parasites. Pyronaridine (2.8 μM) is tenfold more potent at beta-hematin nucleation than chloroquine (40 μM). Both pyronaridine and chloroquine (0.2 and 0.7 μM, respectively) had similar sub-μM inhibition of beta-hematin extension. P. falciparum CamWT-C580Y parasites produce smaller width hemozoin crystals which extend less than isogenic CamWT hemozoin. Stage-specific pulse dose pyronaridine and chloroquine on CamWT-C580Y or CamWT isogenic parasites observed 3- to 4-fold higher pyronaridine IC 50 s compared to 10- to 15-fold higher chloroquine on most CamWT-C580Y to CamWT stages. These findings collectively show that hemozoin nucleation inhibition widens stage-specific pyronaridine activity on P. falciparum drug-resistant parasites.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plasmodium falciparumChloroquineAntimalarialsHemeproteinsNaphthyridinesArtemisininsDrug ResistanceMutationHumansMalaria, Falciparum

Stichwörter der Autor:innen

artemisininchloroquinedrug resistancehemozoinpyronaridine

Substanzen

ChloroquineAntimalarialspyronaridinehemozoinHemeproteinsNaphthyridinesArtemisininsartemisinin

Autor:innen und Institutionen

  • Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Department of Chemical and Biomolecular Engineering, University of Houston, Houston, Texas, USA.
  • Department of Chemistry, University of Houston, Houston, Texas, USA.

ORCID-Profile: David J Sullivan

Förderung

  • NIAID NIH HHS
  • Bloomberg Family Foundation (The Bloomberg Family Foundation)
  • JHSPH | Johns Hopkins Malaria Research Institute, Johns Hopkins Bloomberg School of Public Health
  • HHS | NIH | National Institute of Allergy and Infectious Diseases

Zitieren

APA

Sayeed, A., Atkinson, R., Vekilov, P. G., Rimer, J. D., & Sullivan, D. J. (2025). Stage-specific pharmacodynamic chloroquine and pyronaridine action on artemisinin ring-stage resistant Kelch C580Y mutation Plasmodium falciparum correlates to hemozoin inhibition process. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01208-24

Vancouver

Sayeed A, Atkinson R, Vekilov PG, Rimer JD, Sullivan DJ. Stage-specific pharmacodynamic chloroquine and pyronaridine action on artemisinin ring-stage resistant Kelch C580Y mutation Plasmodium falciparum correlates to hemozoin inhibition process. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.01208-24

BibTeX
@article{Sayeed2025,
  author = {Sayeed, Abeer and Atkinson, Revie and Vekilov, Peter G and Rimer, Jeffrey D and Sullivan, David J},
  title = {Stage-specific pharmacodynamic chloroquine and pyronaridine action on artemisinin ring-stage resistant Kelch C580Y mutation Plasmodium falciparum correlates to hemozoin inhibition process},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  doi = {10.1128/aac.01208-24}
}
Kostenlos starten →